Debut Biotechnology Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 12

Debut Biotechnology General Information

Description

Developer of a cell-free biomanufacturing technology and platform designed to create complex and high-value ingredients. The company's platform harnesses natural enzyme approaches to overcome cell limitations and provide a sustainable, low-cost, and consistent supply of natural ingredients, enabling clients to have access to sustainably produced ingredients.

Contact Information

Website
debutbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
  • 6330 Nancy Ridge Drive
  • Unit 106
  • San Diego, CA 92121
  • United States
+1 (619) 000-0000

Debut Biotechnology Timeline

202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Debut Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 19-Nov-2021 $4M 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 05-Aug-2021 000.00 000.00 00000 Completed Generating Revenue
2. Grant 15-Sep-2020 $1M $2.61M Completed Generating Revenue
1. Seed Round 06-Jan-2020 $2.61M $2.61M 00.000 Completed Generating Revenue
To view Debut Biotechnology’s complete valuation and funding history, request access »

Debut Biotechnology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2 000,000 00.000000 00 000 000 00 000 00.000
Series A-1 000,000 00.000000 00 000.00 000.00 00 000.00 0.000
Seed-2 144,114 $0.000100 8% $5.3 $5.3 1x $5.3 4.49%
Seed-1 337,221 $0.000100 8% $4.24 $4.24 1x $4.24 10.51%
To view Debut Biotechnology’s complete cap table history, request access »

Debut Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cell-free biomanufacturing technology and platform designed to create complex and high-value ingredients.
Discovery Tools (Healthcare)
San Diego, CA
23 As of 2021
000.00
0000000000 0 000.00

000000 0

idunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco l
0000000000000
Boston, MA
000 As of 0000
00.000
000000000 00.000

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Debut Biotechnology Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ginkgo Bioworks Holdings Formerly VC-backed Boston, MA 000 00.000 000000000 00.000
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
000 00000000000000 Venture Capital-Backed Boulder, CO 00 000.00 00000000000 000.00
00000000000 000000 Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 000.00
000000000 Venture Capital-Backed Stockholm, Sweden 00 000.00 00000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Debut Biotechnology Executive Team (3)

Name Title Board Seat Contact Info
Joshua Britton Ph.D Co-Founder, Chief Executive Officer & Board Member
Gregory Weiss Ph.D Co-Founder & Scientific Advisor
Brady Beauchamp Co-Founder
To view Debut Biotechnology’s complete executive team members history, request access »

Debut Biotechnology Board Members (4)

Name Representing Role Since
Cain McClary MD Self Board Member 000 0000
Corinna Chen Self Board Member 000 0000
Daniel Phillips Debut Biotechnology Board Member 000 0000
Joshua Britton Ph.D Debut Biotechnology Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Debut Biotechnology’s complete board members history, request access »

Debut Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Debut Biotechnology Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ACVC Partners Venture Capital Minority 000 0000 000000 0
Cantos Ventures Venture Capital Minority 000 0000 000000 0
Doon Capital Family Office Minority 000 0000 000000 0
Fine Structure Ventures Venture Capital Minority 000 0000 000000 0
Humboldt Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial